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Mycobacterium avium subsp. paratuberculosis causes Johne’s disease (JD) in ruminants. Development of
genetic tools and completion of the M. avium subsp. paratuberculosis genome sequencing project have expanded
the opportunities for antigen discovery. In this study, we determined the seroreactivities of two proteins
encoded at the 5ⴕ and 3ⴕ regions of the MAP1152-MAP1156 gene cluster. MAP1152 encodes a PPE protein, and
MAP1156 encodes a diacylglycerol acyltransferase involved in triglyceride metabolism and classified in the
uncharacterized protein family UPF0089. Recombinant MAP proteins were overproduced and purified from
Escherichia coli as maltose-binding protein (MBP) fusions. Immunoblotting analysis indicated that both
MAP1152 and MAP1156 displayed reactivity against sera of mice and rabbits immunized with live M. avium
subsp. paratuberculosis cells and against samples from naturally infected cattle. In immunoblot assays,
MAP1156 yielded a stronger positive signal than MAP1152 against sera from cattle with JD. An enzyme-linked
immunosorbent assay for the recombinant proteins was developed and used to test preclassified positive and
negative serum samples from naturally infected and noninfected cattle. Samples, with one exception, displayed
no seroreactivity against the MBP-LacZ fusion protein (P > 0.05), the negative-control antigen. MAP1152
displayed seroreactivity against all positive sera but no seroreactivity to the negative sera (P < 0.01). MAP1156
displayed stronger and more variable reactivity than MAP1152, but significant differences were observed
between noninfected and infected cattle (P < 0.05). Otherwise, degrees of reactivity followed the same trend as
the positive reference antigen. In conclusion, both proteins are immunogenic in mice and rabbits, and M. avium
subsp. paratuberculosis-infected cattle mount a humoral response to both MAP1152 and MAP1156 crossreactive epitopes. These findings have potential applications to diagnostics, vaccine production, and elucidation of the immunopathogenesis of JD.
progression is classified into four stages: silent infection and
subclinical, clinical, and advanced clinical disease (61). Despite
the progress made in the analysis of mechanisms of pathogenesis, a diagnostic test of high sensitivity and specificity for
detection of subclinically infected animals has not been developed (15, 19, 27, 33, 34, 39, 50). In this situation, most diseased
animals escape detection, especially during early infection.
Likewise, current vaccines against JD are highly regulated,
have poor efficacy, and interfere with diagnostic tests against
bovine tuberculosis (5, 10, 20, 23, 55).
The information obtained from the completed M. avium
subsp. paratuberculosis genome sequencing project ushered in
the development of new tools for diagnosis and disease control
(29). In the context of our study, approximately 1% of the M.
avium subsp. paratuberculosis genome encodes members of the
PE (Pro-Glu) and PPE (Pro-Pro-Glu) protein families, so denominated by their characteristic motifs at their N-terminal
domains. These genes were initially discovered in the Mycobacterium tuberculosis genome, which dedicates approximately
10% of its coding capacity to these elements. Cole et al. hypothesized that the PE and PPE families may have immunological importance, being the main source of antigenic variation (14, 52, 56). This quantitative difference in coding capacity

Mycobacterium avium subsp. paratuberculosis, one of the
slowest-growing mycobacteria (28), is the etiologic agent of
Johne’s disease (JD) in ruminants (11, 24). JD is a chronic
enteritis with significant economic impact and worldwide distribution (23, 51, 53, 57). A JD regression model estimates that
losses to the dairy industry range from $40 to $227 per inventoried cow per year (24, 40). JD has lower prevalence in beef
herds, but this disease still has a negative impact on trade (38,
42, 60). Concerns for human health have also been raised,
since M. avium subsp. paratuberculosis has the potential to be
a zoonotic and/or food-borne pathogen, as evidenced by its
possible linkage to Crohn’s disease (6, 8, 9, 21).
The physiology and pathogenesis of M. avium subsp. paratuberculosis have been reviewed (24, 61). Neonates and juvenile animals are the most susceptible to infection. Disease
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seems to be rooted in the evolutionary expansion of these
families as microorganisms of the Mycobacterium tuberculosis
complex diverged from the M. avium group (22). M. avium
subsp. paratuberculosis possesses only the ancestral members
of these families. Thus, functional analyses of these proteins
are significant for the development of vaccines and diagnostics,
as well as for the understanding of their roles in JD pathogenesis.
This study focused on the MAP1152-MAP1156 gene cluster,
as the Tn5367 transposon insertion in the colony morphology
M. avium subsp. paratuberculosis strain K-10 mutant with an
attenuated phenotype in bovine macrophages (31), has now
been mapped ca. 0.6 kb upstream from MAP1152. To evaluate
the potential role of this gene cluster in M. avium subsp. paratuberculosis immunobiology, we performed further bioinformatic analysis and determined the reactivities of MAP1152 and
MAP1156 against sera from mice and rabbits immunized with
live M. avium subsp. paratuberculosis and against samples from
naturally infected cattle.
MATERIALS AND METHODS
Cloning, expression, and purification of M. avium subsp. paratuberculosis
proteins in Escherichia coli. MAP1152 and MAP1156 coding sequences were
amplified from M. avium subsp. paratuberculosis K-10 genomic DNA and cloned
into the pMAL-c2 translational fusion expression vector using the primers 5⬘-A
TCCTCTAGAATGGATTTCGGGTCGTTACCGC-3⬘ and 5⬘-GCGCAAGCT
TCTATTTCGCGTTCGGCG-GAATG-3⬘ for MAP1152 and 5⬘-ATCCTCTAG
AATGAAACGGCTTTCGAGTGTCG-3⬘ and 5⬘-GCGCAAGCTTCAGCCGG
TCTCGCCCGCGGCG-3⬘ for MAP1156. Both primer pairs amplified the
corresponding full-length coding sequence. The vector and amplification products were each digested with XbaI and HindIII. Following overnight ligation at
4°C, the products were transformed into E. coli DH5␣ and selected on LB agar
plates containing 0.10 mg/ml ampicillin. Drug-resistant colonies were screened
by PCR using the amplification primers, and plasmid DNA for sequencing
analysis was produced from positive colonies to confirm each clone. E. coli
protein lysates from verified clones were prepared as previously described (47).
Proteins used in this study were expressed and purified as recombinant maltosebinding protein (MBP) N-terminal fusions (e.g., LacZ, MAP1152, and
MAP1156; referred to here by these short names, with the understanding that all
recombinant proteins used in the experiments were fusion products). These
MBP-tagged recombinant proteins were overexpressed by induction of 1.0-liter
LB broth cultures with 0.3 mM isopropyl-␤-D-thiogalactopyranoside (Sigma
Chemical Company, St. Louis, MO) for 2.5 h with shaking at 37°C. E. coli cells
were harvested by centrifugation at 4,000 ⫻ g and resuspended in column buffer,
and the cell suspension was subjected to a freeze-thaw cycle at ⫺20°C and
sonicated under conditions described previously (1). The resulting crude extracts
were purified by affinity chromatography with an amylose resin (New England
Biolabs). Purified protein yields were determined from eluted fractions with a
NanoDrop spectrophotometer set at 280 nm. The most concentrated fractions
were pooled and dialyzed in Slide-A-Lyzer cassettes (Pierce Biotechnology Inc.,
Rockford, IL) immersed in 1.5 liters of phosphate-buffered saline (PBS; 150 mM
NaCl, 10 mM Na2HPO4; pH 7.4) with three exchanges at 4°C. Purified protein
aliquots were stored at ⫺20°C. After thawing the aliquots, protein yield was
reassessed by a modified Lowry assay using bovine serum albumin (BSA) as the
standard. E. coli DH5␣ harboring the parental plasmid pMAL-c2 was expressed,
purified, and used as a control. Purified protein from this control strain consists
of an MBP fusion (overall mass, 42 kDa) with the LacZ alpha peptide (8 kDa).
Each recombinant protein was further evaluated by using GelCode blue (Pierce
Biotechnology Inc., Rockford, IL)-stained SDS-PAGE gels to assess purity and
expected sizes.
Electrophoresis and immunoblot analysis. Gel electrophoresis was performed
using 12% (wt/vol) polyacrylamide gels. Electrophoretic transfer of proteins onto
pure nitrocellulose was carried out using a TransBlot cell (Bio-Rad Laboratories,
Richmond, CA) with sodium phosphate buffer (25 mM; pH 7.8) at 0.8 A for 90
min. After transfer, filters were blocked with PBS plus 2% BSA and 0.1% Tween
20 (BSA-PBST). Cattle serum samples (Table 1) were diluted 1:500 in BSAPBST, and the rabbit and mouse sera were diluted 1:1,000. As necessary, subclinical (stage 2) versus clinical (stage 3) infections were assessed by fecal counts,
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TABLE 1. Cattle serum samples used in the study
Serum sample

Original
classification
(Idexx test)

183
2075
184
805
45
193

⫹
⫹
⫹
⫹
⫹
⫺

Cow 2291

⫺

Cow 47
Positive controlb
EDNA
Cow 308
2010-07
Negative controld
J53-90
Cow 559
3438-08

⫹
⫹
⫹
⫹
⫹
⫺
⫺
⫺
⫺

Cow
Cow
Cow
Cow
Cow
Cow

Type of infection
Natural (JD)
Natural (JD)
Natural (JD)
Natural (JD)
Natural (JD)
Experimental, with M.
avium hominissius
Experimental, with M.
bovis strain 95-1315
Natural (JD)
Natural (JD)
Natural (JD)
Natural (JD)
Natural (JD)
None
None
None
None

Source
NADCa
NADC
NADC
NADC
NADC
NADC
NADC
NADC
Idexx Laboratories
NADC
NADC
Nebraska dairyc
Idexx Laboratories
Nebraska beef herdc
NADC
Nebraska dairyc

a

NADC, National Animal Disease Center, Ames, IA.
Positive-control serum provided with the Idexx kit, derived from a single
naturally infected Holstein cow (Idexx Technical Service).
c
Dairy or beef cattle of the University of Nebraska Lincoln Veterinary Diagnostic Center, Lincoln, NE.
d
Negative-control serum provided with the Idexx kit, derived from a single
Holstein cow residing in a herd that tested negative for paratuberculosis by
whole-herd testing over multiple years (Idexx Technical Service).
b

as described previously (62). For detection of MBP, a high-titer murine antiMBP monoclonal antibody was diluted 1:10,000. Each blot was incubated at
room temperature for 2 h with gentle rocking. After three washes in PBS plus
0.1% Tween 20, blots were incubated for 1.5 h in a horseradish peroxidase
(HRP)-labeled goat anti-bovine detection antibody that was obtained from
Southern Biotechnology and diluted 1:10,000 in PBS-BSA. The blots were again
washed three times as described above and developed for chemiluminesence
using Supersignal detection reagents (Pierce).
Quantitative analysis of band intensities on immunoblots. Band intensity was
determined using the Adobe Photoshop CS4 extended application measurement
tool. This version has the ability to record pixel gray values using the default
measurement scale (1 pixel ⫽ 1 pixel). Each spot was measured identically by
using a defined window area. Values were exported into a spreadsheet for further
analysis. The background statistics were calculated by determining the means
and standard deviations of the bands that had the least signal intensity within
each output graph. Each intensity score was normalized to this calculated background intensity.
ELISA. An enzyme-linked immunosorbent assay (ELISA) was developed to
quantify the reactivities of MAP1152 and MAP1156 proteins with a subset of
serum samples from cattle with known exposure to M. avium subsp. paratuberculosis (Table 1). Antigen (0.010 mg per well) was bound to BD Falcon Pro-Bind
96-well plates overnight at 4°C. Antigen was diluted in 1.0 M sodium carbonate
buffer (pH 9.8), and 0.1 ml of solution was bound in each well. After overnight
incubation, the plate was washed five times with PBS and blocked with 0.3 ml
BSA-PBST for 2 to 3 h at room temperature. The ELISA was performed as per
the instructions provided with the HerdChek ELISA kit (Idexx Laboratories,
Westbrook, ME). Briefly, sera were diluted 1:25 in either BSA-PBST or the
buffer supplied by Idexx containing Mycobacterium phlei antigen for clarification.
Diluted serum was applied (0.1 ml) to each well and incubated for 30 min at
room temperature, plates were washed five times with PBS, and secondary
antibody conjugate (HRP-conjugated rabbit anti-bovine IgG) was applied (0.1
ml/well) and incubated for 30 min at room temperature. After additional washing
steps, 0.1 ml tetramethylbenzadiene (TMB) was added, and the subsequent
reaction was stopped with the supplied SDS Stop solution as the appropriate
color developed. Absorbance was read at 650 nm with a Molecular Devices
Vmax kinetic microplate reader and translated with the xChek software from
Idexx. The sample-to-positive (S/P) ratios for each antigen were calculated based
on optical density (OD) values, as follows: [(OD of serum sample ⫺ OD of
negative-control serum)]/[(OD of positive-control serum ⫺ OD of negativecontrol serum)], as described for the Idexx HerdChek assay. Statistical analysis of
ELISA results was performed using SAS 9.2 for Windows (SAS Institute Inc.,
Cary, NC). To compare average absorbances of all seropositive cattle samples to
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FIG. 1. Genomic map of PE, PPE, and UPF genes in M. avium
subsp. paratuberculosis K-10 (MAP). Genes encoding PE (shown as
bars inside of the circular chromosome), PPE (bars crossing the circular chromosome), and UPF (bars outside the circle) protein family
members are shown. No PGRS protein-coding sequences were found.
(Inset) MAP1152-MAP1156 genomic region, indicating genes encoding PPE proteins MAP1152, MAP1153, and MAP1155 (black boxes),
UPF protein MAP1156 (gray box), hypothetical protein MAP1154
(dark patterned box), and MAP1150c and MAP1151c (light patterned
boxes). Arrowed boxes indicate the direction of transcription.

the seronegative group, mixed model regression (MIXED) analysis was performed, factoring the repeated measures for day and serum sample. To evaluate
within- and between-antigen serum combination differences, the generalized
linear mixed models regression (GLIMMIX) analysis was used. A P value of
⬍0.05 was considered significant.

RESULTS
Bioinformatic analysis of the MAP1152-MAP1156 gene
cluster. Nine PE and 37 PPE protein genes are scattered
around the M. avium subsp. paratuberculosis chromosome (Fig.
1). The major PPE cluster is at 1.66 Mb in the clockwise
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direction in the published genome sequence (29) and comprises MAP1514, encoding a PE protein, and six PPE genes.
The MAP1152-MAP1156 region of interest for this study is the
second major cluster and is located 1.21 Mb in the clockwise
direction. This region encodes the PPE proteins MAP1152
(40.8 kDa), MAP1153 (45.8 kDa), and MAP1155 (32.3 kDa)
(Fig. 1, inset). This region also encodes a putative open reading
frame (ORF) of unknown function (MAP1154; 11.8 kDa) and
MAP1156 (50.7 kDa), a member of the uncharacterized
protein family (UPF0089) (http://pfam.sanger.ac.uk/family
/PF03007). The M. avium subsp. paratuberculosis genome encodes nine UPF0089 family genes, and MAP1156 is the only
member that is immediately adjacent to a PPE gene (Fig. 1).
This cluster does not encode a PE protein sequence.
It is tempting to speculate that genes in the MAP1152MAP1156 region are organized in a functional unit, since
ORFs further upstream and downstream are transcribed from
the complementary strand with short (e.g., ⬍200-bp) intergenic regions. However, more stringent predictions indicate
that only MAP1152 and MAP1153 are organized in a true
operon with an estimated probability that a pair of genes is in
the same operon (pOp) value of 0.842 (http://www
.microbesonline.org/operons/gnc262316.html) (44, 45). Nonetheless, the genes in this cluster may comprise more than one
operon.
The proximal (MAP1152) and distal (MAP1156) ORFs in
the cluster were selected for immunological tests of humoral
immunity in infected and noninfected animals. MAP1152 encodes a typical PPE protein of 416 amino acids with a predicted molecular mass of 40.8 kDa (Table 2). Protein structure
analysis predicts for the best model three trans-membrane helices (48; http://www.predictprotein.org), consistent with a surface or membrane localization, as shown for other PPE proteins (7, 25, 32, 36, 43). MAP1156 is a protein of 464 amino
acids with a predicted molecular mass of 50.7 kDa. Protein
structural analysis for the best fit model predicts one transmembrane helix, suggesting surface localization (48). Both
MAP1152 and MAP1156 have homologous sequences in both
M. avium subsp. paratuberculosis and other mycobacterial genomes. Further bioinformatic analysis of the ORFs in the
cluster is presented in Table 2.

TABLE 2. Characterizations of ORFs MAP1152 to MAP1156
ORF

Size
(no. of aa, mass)a

H37Rv homologb/E-valuec

MAP1152
MAP1153

416, 40.7
454, 45.7

Rv1808 (PPE32)/8.0 E⫺78
Rv1809 (PPE33)/1.0 E⫺84

PPE, GxxSVPxxW
PPE, GxxSVPxxW

MAP1154
MAP1155

117, 11.7
320, 32.2

Rv1810/8.0 E⫺19
Rv1807 (PPE31)/4.0 E⫺24

DUF732 superfamily
PPE, GxxSVPxxW

MAP1156

464, 50.6

Rv1425/0.0

UPF0089

Domain, motifa,c

Comment(s)d

Three MH
Coding sequence starts 7 bp downstream
from MAP1152; three MH
Hypothetical protein; no MH
Attenuating mutation in M. tuberculosis
homolog (49); two MH
M. tuberculosis homolog encodes enzyme
with low TGS activity (16); possibly
one MH

a
Data are based on National Center for Biotechnology Information (NCBI) database output. Sizes are reported as the number of amino acids (aa) and as molecular
mass (in kilodaltons).
b
Data entries based on the Pfam database (http://pfam.sanger.ac.uk/family). Most homologous M. tuberculosis proteins are not necessarily orthologs (22).
c
E-values (determined using the Blastp suite) are formatted as described in the BLAST help manual (http://www.ncbi.nlm.nih.gov/blast/blast_help.shtml).
d
MH, membrane helices (determined via the PredictProtein server 关http://www.predictprotein.org兴 for protein analysis 关PHDhtm output兴).

108

BANNANTINE ET AL.

FIG. 2. SDS-PAGE and immunoblot analysis of recombinant M.
avium subsp. paratuberculosis MAP1152 and MAP1156 proteins.
Shown is a 12% SDS-PAGE gel, stained with GelCode blue, along with
three corresponding immunoblots containing purified recombinant fusion proteins. Antibody or serum samples used to probe the immunoblot are indicated beneath the panels: MBP MAb, monoclonal antibody against the maltose-binding protein; mouse 160, serum derived
from a mouse immunized with live M. avium subsp. paratuberculosis
cells; rabbit 273, serum derived from a rabbit immunized with live M.
avium subsp. paratuberculosis cells. Size standards, reported in kDa,
are indicated to the left. Assignments for the gel and blots were as
follows: lane 1, protein size standards; lane 2, MAP1152; lane 3,
MAP1156; lane 4, LacZ.

Seroreactivity of recombinant proteins by immunoblot analysis. Purified recombinant proteins MAP1152 and MAP1156
were subjected to SDS-PAGE and immunoblot analyses.
Equal amounts of both proteins were examined by SDS-PAGE
to verify that their migration corresponded with their molecular size (Fig. 2, SDS-PAGE). Both fusion proteins migrated to
the expected positions between the 75-kDa and 100-kDa protein markers, with MAP1156 (90.6 kDa) located slightly higher
than MAP1152 (82.8 kDa). Likewise, LacZ (42 kDa) migrated to a position below the 50-kDa marker. These data
indicate that the MBP method resulted in protein preparations
of the necessary purity and yield to carry out further testing.
MAP1156 did show multiple bands, in contrast to the discrete
single bands observed for MAP1152 and LacZ. Immunoblot
quality control analysis was also performed, using a monoclonal antibody developed to the MBP affinity tag. All three MBP
fusion proteins were detected by this antibody (Fig. 2, MBP
MAb). The additional bands observed in the MAP1156 preparation likely represent degradation products with the same N
terminus, as the fast-migrating bands reacted also with the
MBP monoclonal antibody.
The immunogenicity of the recombinant proteins was tested
by immunoblotting using immune mouse (C57BL/6) or rabbit
(New Zealand White) serum from animals immunized with a
live preparation of M. avium subsp. paratuberculosis, as described previously (2). The mouse serum displayed little to no
reactivity to MAP1152 but strong reactivity to MAP1156, with
the most intense band migrating between the 50- and 75-kDa
markers (Fig. 2, mouse 160). The rabbit immune serum
showed strong reactivities to both proteins (Fig. 2, rabbit 273).
Reactivity against the LacZ antigen carrying the MBP tag was
used as a negative control. The mouse serum displayed no
MBP-LacZ reactivity (Fig. 2, mouse panel, lane 4), and only a
weak reaction was observed with the rabbit serum (Fig. 2,
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FIG. 3. Western blot analysis of antibody responses to MAP1152
and MAP1156 in naturally infected cattle. Immunoblots containing
MAP1152 and MAP1156 were probed with sera from five cows (183,
2075, 84, 805, and 45) naturally infected with M. avium subsp. paratuberculosis (A) or from two additional cows experimentally infected
with M. avium or M. bovis (B). Size standards, reported in kDa, are
indicated to the left. Assignments for the blots were as follows: lane 1,
protein size standards; lane 2, MAP1152; lane 3, MAP1156; lane 4,
LacZ.

rabbit panel, lane 4). Thus, the MBP tag yielded no to minimal
reactivity in these immunoblot assays.
Immunoblot assays were also performed with sera from five
cattle naturally infected with M. avium subsp. paratuberculosis
(Fig. 3A, 183, 2075, 184, 805, and 45). MAP1156 (Fig. 3A, lane
3, all panels) showed higher levels of reactivity than MAP1152
(Fig. 3A, lane 2, all panels). Furthermore, densitometry analysis (see Table S1 in the supplemental material) enabled a
semiquantitative comparison and showed that MAP1156 displayed 2- to 5-fold more seroreactivity than MAP1152 among
these M. avium subsp. paratuberculosis-seropositive samples.
Conversely, weak reactivity was observed with sera from cattle
experimentally infected with M. avium or M. bovis (Fig. 3B).
None of the serum samples yielded any background activity
against the LacZ antigen or the MBP tag (Fig. 3, lane 4, each
panel).
We also followed the reactivity of the proteins against serum
samples taken at different time points during natural infection.
Samples corresponded to bleeds taken 9 to 14 months apart,
corresponding to disease progression from subclinical to clinical infection. Results obtained with these samples (Fig. 4)
indicated that MAP1152 did not react with any of the serum
samples (Fig. 4, upper panel, lanes 1 to 4), while MAP1156
(Fig. 4, middle panel, lanes 1 to 4) and M. avium subsp. paratuberculosis K-10 whole-cell extract (Fig. 4, lower panel) displayed increasing reactivities with samples from the subclinical
(Fig. 4, lanes 1 and 2) and clinical stages (Fig. 4, lanes 3 and 4).
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FIG. 4. Western blot analysis of antibody responses to MAP1152
and MAP1156 during the course of JD. Immunoblots of MAP1152
(upper gel), MAP1156 (middle gel), and K-10 whole-cell extract (lower
gel) were probed with serum samples withdrawn from a naturally
infected cow (cow 47) at various times during the course of the experiment: lane 1, first bleed, subclinical infection; lane 2, 12 months after
first bleed, borderline clinical/subclinical infection; lane 3, 26 months
after first bleed, clinical infection; lane 4, 35 months after first bleed,
advanced clinical infection; lane 5, anti-MBP monoclonal antibody
control. Size standards (in kDa) are indicated to the left.

Both proteins reacted with the anti-MBP monoclonal antibody
control (Fig. 4, lane 5), although MAP1152 yielded a weaker
reaction.
Seroreactivity of recombinant protein with sera from M.
avium subsp. paratuberculosis-infected and noninfected cattle
by ELISA. As the ELISA technology is readily adaptable to
diagnostic applications, we also determined the reactivities of
MAP1152 and MAP1156 by this method. In addition, this
assay is generally performed to evaluate the antigen-antibody
reaction in the absence of denaturing agents. Thus, both linear
and conformational epitopes may contribute to the overall
reactivity. Due to limiting amounts of serum samples, the
ELISA was performed using archived serum samples which
were previously evaluated with the Idexx test at the University
of Nebraska—Lincoln Veterinary Diagnostic Laboratory (Table 1).
Each sample was tested in triplicate against LacZ (negativecontrol antigen) and on three different days in duplicate (day
3) or triplicate (days 1 and 2) to evaluate reproducibility and
performance against MAP1152, MAP1156, and a standard M.
avium subsp. paratuberculosis antigen control (the Idexx antigen, a proprietary mixture of M. avium subsp. paratuberculosis
antigens) included in the Idexx test kit (see Table S2 in the
supplemental material). Each antigen showed low reactivity
and low variability as tested against seronegative serum samples from noninfected cattle. As expected, the differences in
mean absorbance values for samples from M. avium subsp.
paratuberculosis-infected versus noninfected cattle were statistically significant for MAP1152 (P ⱕ 0.01), MAP1156 (P ⱕ
0.05), and the Idexx antigen (P ⱕ 0.001), with more variable
results for MAP1156 and the Idexx antigen (see Table S3 in the
supplemental material). In contrast, the difference in absorbance means was not significant for the LacZ negative-control
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FIG. 5. Seroreactivities of MAP1152 and MAP1156 recombinant
proteins to infected and noninfected cattle. Antigen (0.010 mg) reactivity was evaluated by ELISA against sera from cattle naturally infected with M. avium subsp. paratuberculosis (filled bars) or sera from
culture-negative cattle (open bars). Each serum sample was diluted
1:25 in Idexx dilution buffer. Each column represents mean absorbance
(from triplicate measurements against LacZ; averaged from measurements on three different days in duplicate or triplicate for other antigens [see Table S2 of the supplemental material]) per antigen, ⫾
standard errors of the means from noninfected cattle (left columns) or
infected cattle (right columns), as evidenced from the original classification of serum samples. Significance levels are indicated as follows:
ⴱ, P ⱕ 0.05; ⴱⴱ, P ⱕ 0.01; ⴱⴱⴱ, P ⱕ 0.001.

antigen carrying the MBP tag (P ⬎ 0.05). However, the reactivity of seropositive samples against LacZ was also more variable, as indicated by the error bars in Fig. 5. With the M. avium
subsp. paratuberculosis capture antigens we were able to differentiate, in the combined analysis, between the groups of
seropositive and seronegative samples. Thus, M. avium subsp.
paratuberculosis infection results in a humoral response directed against epitopes present in MAP1152, MAP1156, and
the Idexx antigen. However, absorbance values obtained using
MAP1152 and MAP1156 as the capture antigens were lower
than those attained with the Idexx capture antigen. This performance is not surprising, because these results were obtained
with the standardized Idexx test protocol.
Comparative analysis of the reactivity of each serum-antigen
combination was also carried out (Fig. 6). Reactivity trends
were similar for both MAP1152 and MAP1156, as all samples
with higher absorbance readings for MAP1152 also yielded
higher values for MAP1156. The Idexx antigen followed a
similar trend, except for the positive control, as all three M.
avium subsp. paratuberculosis antigens yielded similar absorbance values. In contrast, three seropositive samples (EDNA,
308, and 2010-07) yielded significantly higher absorbance values for the Idexx antigen than for MAP1152 and MAP1156.
No samples were expected to yield above-background absorbance readings with LacZ, the negative antigen control carrying the MBP tag. However, the EDNA serum sample displayed
approximately four-times-higher absorbance readings than any
other sample.
Both statistical analysis using GLIMMIX and calculation of
S/P ratios for the Idexx antigen yielded the same classification
as the original test (see Tables S2 and S4 in the supplemental
material). Because cutoff values for S/P ratios are dependent
on the particular assay procedure, capture antigen, and selection of an appropriate positive-control serum, GLIMMIX provides the more accurate analysis for the recombinant antigens.
Absorbance means for each antigen-serum combination were
compared to each other, and samples were classified as positive
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FIG. 6. Individual responses of serum samples from infected and
noninfected cattle to recombinant antigens. Antigen (0.010 mg) reactivity was evaluated by ELISA against sera from cattle naturally infected with M. avium subsp. paratuberculosis and sera from culturenegative cattle. Each serum was diluted 1:25 in Idexx dilution buffer.
Each column represents mean absorbance (triplicate measurements
against LacZ; average measurements on three different days in duplicate or triplicate for other antigens, as indicated in Table S2 of the
supplemental material) per antigen, ⫾ standard errors of the means
from noninfected (⫺) or infected (⫹) cattle, as evidenced from the
original classification of serum samples. The reaction to each antigen
is indicated (see inset for pattern key).

or negative based on the P value obtained for the comparison
against the negative-control serum for the corresponding test
antigen. This analysis indicated that the nonspecific MBPLacZ antigen control identified all samples, except EDNA, as
seronegative; in contrast, antigens MAP1152 and MAP1156
misclassified only the seropositive sample 2010-07 as seronegative (see Table S4). Thus, overall, all M. avium subsp. paratuberculosis antigens yielded a classification of serum samples
consistent with the original test.
DISCUSSION
Development of effective strategies for the control of JD
remains one of the most challenging issues in animal health
(15, 19). Advances in M. avium subsp. paratuberculosis genomics and molecular genetics provide an integrated rational approach to solve this problem (1, 3, 29). In this context, the
search for new diagnostic tests can be most effective if combined with novel approaches to vaccination and knowledge of
what the test indicates regarding the underlying mechanisms of
disease pathogenesis. Targeting of the MAP1152-MAP1156
gene cluster was based on the identification of an attenuating
mutation possibly related to the expression of this cluster and
a potential role of the encoded proteins as B- or T-cell antigens. An attenuated mutant may serve as a candidate live
attenuated vaccine strain and the protein as a subunit vaccine
or diagnostic indicator; all relevant aspects are combined into
an integrated approach.
In this study, we demonstrated that both MAP1152 and
MAP1156 encode reactive B-cell epitopes, a result predicted
from the surface localization implied by in silico analysis (Table
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2). This finding is also consistent with prior experimental evidence on other PE/PPE proteins. For example, the M. tuberculosis protein Rv2430c (PE25) was identified as a strong Bcell antigen (12), and the seroreactivity of MAP3420 c was
demonstrated in cattle (36). In contrast, antigens MAP1518
(Map41; ortholog of Rv1808 [PPE32]) and MAP3184 (Map39;
ortholog of Rv3135 [PPE50]), the M. avium strain 104 MaPE
protein, and the cell wall-associated M. tuberculosis protein
Rv3873 (PPE68) serve as T-cell antigens (35, 37, 41).
MAP1152 and related PPE proteins MAP1153 and
MAP1155 are members of the ancestral PPE sublineage IV
(22). The genes encoding these proteins belong to an ancestral
cluster that underwent duplication events from ancestral
ESAT-6 clusters but without a concomitant duplication of the
ESAT-6 genes and, thus, these paralogs are no longer associated with the ESAT-6 genes. PE/PPE genes are usually organized in operons encompassing at least several PE and/or PPE
members (46, 58). Biochemical evidence indicates that PE and
PPE function in pairwise combinations of interacting proteins
exposed to the cell surface (18, 46, 54), with the larger-sized
PPE proteins providing a pocket for the PE partner (54).
However, MAP1152 is organized in a cluster devoid of coding
sequences for PE proteins. Because the probability of PPE
proteins participating in pairwise associations decreases for
unlinked PE and PPE genes (46), the function of MAP1152
may or may not require a PE partner. Instead, MAP1152 may
play additional roles in the mechanisms of pathogenesis, as
shown for other PE/PPE proteins. For example, M. tuberculosis
transposon mutants of the PE/PPE genes Rv1807 (PPE31),
Rv3872 (PPE35), and Rv3873 (PPE68) are attenuated in mice
(49). Likewise, a transposon mutant in the M. avium PPE gene
homologous to Rv1787 (PPE25) displayed impaired growth in
macrophages, reduced virulence in mice, and failed to prevent
phagosome acidification (26, 30). Thus, a group of PE and PPE
proteins may be necessary for intracellular survival.
MAP1156 is also a B-cell antigen, with stronger reactivity
than MAP1152 in Western blot assays, a property also consistent with its reactivity with immune mouse and rabbit sera and
inferred surface localization. MAP1156 belongs to the uncharacterized protein family UPF0089. M. tuberculosis encodes 15
members of this family, which includes proteins with triacylglycerol synthase (TGS) activity (16). The M. tuberculosis ORF
Rv1425 is the closest homolog to MAP (Table 2), but this ORF
has been shown not to possess significant TGS activity, at least
under the conditions tested. One possible role consistent with
a strong humoral reaction is that this ORF “hitchhiked” with
M. avium subsp. paratuberculosis into a coexpression unit that
modulates the immune response. Microorganisms of the M.
tuberculosis complex possess a large number of PE-PGRS proteins that are associated with immunoregulatory roles (4, 17).
However, as indicated above, the M. avium subsp. paratuberculosis evolutionary lineage separated prior to the further expansion of the ESAT-6 region V that gave rise to the PEPGRS and PPE-MPTR sublineage V PE/PPE proteins (22).
Thus, the absence of PE-PGRS proteins may require the recruitment of other proteins, for example, MAP1156, to play
this immunomodulatory role. Future experiments will be directed to identify T-cell epitopes in both MAP1152 and
MAP1156. These tests are indispensable for determining the
major roles of these antigens in immunopathogenesis. For
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example, it is possible that the PPE protein MAP1152, the
weaker B-cell antigen in Western immunoblotting analyses,
may elicit a predominant T-cell response early in infection,
with MAP1156 exerting a countermodulating B-cell response,
most favorable for M. avium subsp. paratuberculosis to maintain a chronic infection. This hypothesis is consistent with the
increasing MAP1156 seroreactivity observed with serum samples withdrawn as JD progressed from the subclinical to clinical stage (Fig. 4). However, a more detailed study of linear
and conformational epitopes in these proteins, especially for
MAP1152, should be undertaken, as conformational epitopes
may not be reactive in Western immunoblot assays.
The B-cell reactivities of both MAP1152 and MAP1156 in
Western blot assays and the ELISA with serum samples from
M. avium subsp. paratuberculosis-infected cattle are likely associated with private rather than cross-reactive or shared
epitopes from related M. avium subsp. paratuberculosis proteins. In this context, the closest paralog to MAP1152 is
MAP1518, with 47% identity. Likewise, the closest paralog to
MAP1156 is MAP1969c, with 38% identity (see Table S5 in the
supplemental material). The low degree of reactivity of
MAP1152 in the immunoblot assays against sera from M. bovis-infected animals may be explained in a similar manner, as
the closest homolog (Mb1837) shares only 50% identity. In
contrast, the low reactivity of MAP1156 against the M. bovis
serum, and of MAP1152 and MAP1156 against M. avium
hominissuis serum, may be associated with low expression levels in these microorganisms. Otherwise, the corresponding
proteins are highly homologous, with 86 to 99% identity (see
Table S5) and, thus, likely to be highly cross-reactive, as most
epitopes are shared. Moreover, the MAP1152-MAP11156
cluster organization is conserved between M. avium subsp.
paratuberculosis and M. avium 104 (a sequenced isolate of M.
avium subsp. hominissuis), with both genomes possessing
highly homologous genes within this region. However, sequence divergence with M. avium 104 occurs upstream from
MAP1152 that could affect gene regulation. Nonetheless, to
substantiate these findings for the development of diagnostic
tests, it will be necessary to test a larger group of cattle infected
with M. bovis, M. avium subspecies, and other environmental
species, such as Mycobacterium kansasii.
Interestingly, MAP1152, MAP1156, and the Idexx antigen
yielded similar absorbance values against the standardized
Idexx positive-control bovine serum included in the Idexx kit,
which is from a single naturally infected Holstein cow (Table
1). However, the other three seropositive clinical samples reacted more strongly with the Idexx antigen (Fig. 6). As indicated above, these results may be due to methodological aspects, as the overall assay optimization was based on the Idexx
protocol. Alternatively, or by compounding effects, the increased reactivity in these samples against the Idexx antigen
may in part reflect the presence of cross-reactive antibodies
against the various M. avium subsp. paratuberculosis proteins
present in the Idexx antigen.
In summary, M. avium subsp. paratuberculosis-infected cattle
mount a humoral response to both MAP1152 and MAP1156.
Further research is needed to determine the values of these
recombinant proteins as diagnostic capture antigens, subunit
vaccines, markers of disease progression, and their suitability
for the development of tests for diagnosis of infected from

111

vaccinated animals (DIVA), coupled with the development of
live attenuated deletion mutant marker vaccines (13, 59).
ACKNOWLEDGMENTS
This work was supported by funds from the Johne’s Disease Integrated Program (J.P.B. and R.G.B.) and USDA-ARS (J.P.B.), USDA
grant CSREES-NRI 2004-35204-14231 (R.G.B. and C.J.C.), the
BARD program grant IS-3673-05C (R.G.B.), USDA Animal Health
Project NEB14-141 (R.G.B.), and the Department of Veterinary and
Biomedical Sciences at the University of Nebraska (D.R.S., D.S.M.,
and R.G.B.).
We thank Malory Becker for her assistance to A.L.P. in preparation
of materials and reagents. We thank Steve Kachman for assistance
with SAS analysis.
REFERENCES
1. Bannantine, J. P., and M. L. Paustian. 2006. Identification of diagnostic
proteins in Mycobacterium avium subspecies paratuberculosis by a whole
genome analysis approach. Methods Mol. Biol. 345:185–196.
2. Bannantine, J. P., and J. R. Stabel. 2001. Identification of two Mycobacterium avium subspecies paratuberculosis gene products differentially recognised by sera from rabbits immunised with live mycobacteria but not heatkilled mycobacteria. J. Med. Microbiol. 50:795–804.
3. Bannantine, J. P., et al. 2008. Development and use of a partial Mycobacterium avium subspecies paratuberculosis protein array. Proteomics 8:463–
474.
4. Banu, S., et al. 2002. Are the PE-PGRS proteins of Mycobacterium tuberculosis variable surface antigens? Mol. Microbiol. 44:9–19.
5. Begg, D. J., and J. F. T. Griffin. 2005. Vaccination of sheep against M.
paratuberculosis: immune parameters and protective efficacy. Vaccine 23:
4999–5008.
6. Bernstein, C. N., J. F. Blanchard, P. Rawsthorne, and M. T. Collins. 2004.
Population-based case control study of seroprevalence of Mycobacterium
paratuberculosis in patients with Crohn’s disease and ulcerative colitis.
J. Clin. Microbiol. 42:1129–1135.
7. Bottai, D., and R. Brosch. 2009. Mycobacterial PE, PPE and ESX clusters:
novel insights into the secretion of these most unusual protein families. Mol.
Microbiol. 73:325–328.
8. Chacon, O., L. E. Bermudez, and R. G. Barletta. 2004. Johne’s disease,
inflammatory bowel disease, and Mycobacterium paratuberculosis. Annu.
Rev. Microbiol. 58:329–363.
9. Chamberlin, W., G. Ghobrial, M. Chehtane, and S. A. Naser. 2007. Successful treatment of a Crohn’s disease patient infected with bacteremic Mycobacterium paratuberculosis. Am. J. Gastroenterol. 102:689–691.
10. Chen, L. H., et al. 2008. Immune responses in mice to Mycobacterium avium
subsp. paratuberculosis following vaccination with a novel 74F recombinant
polyprotein. Vaccine. 26:1253–1262.
11. Chiodini, R. J., H. J. Van Kruiningen, and R. S. Merkal. 1984. Ruminant
paratuberculosis (Johne’s disease): the current status and future prospects.
Cornell Vet. 74:218–262.
12. Choudhary, R. K., et al. 2003. PPE antigen Rv2430c of Mycobacterium
tuberculosis induces a strong B-cell response. Infect. Immun. 71:6338–6343.
13. Cirillo, J. D., C. K. Stover, B. R. Bloom, W. R. Jacobs, Jr., and R. G. Barletta.
1995. Bacterial vaccine vectors and bacillus Calmette-Guerin. Clin. Infect.
Dis. 20:1001–1009.
14. Cole, S. T., et al. 1998. Deciphering the biology of Mycobacterium tuberculosis
from the complete genome sequence. Nature 393:537–544.
15. Collins, M. T., et al. 2005. Evaluation of five antibody detection tests for
diagnosis of bovine paratuberculosis. Clin. Diagn. Lab. Immunol. 12:685–
692.
16. Daniel, J., et al. 2004. Induction of a novel class of diacylglycerol acyltransferases and triacylglycerol accumulation in Mycobacterium tuberculosis as it
goes into a dormancy-like state in culture. J. Bacteriol. 186:5017–5030.
17. Delogu, G., and M. J. Brennan. 2001. Comparative immune response to PE
and PE_PGRS antigens of Mycobacterium tuberculosis. Infect. Immun. 69:
5606–5611.
18. Delogu, G., et al. 2004. Rv1818c-encoded PE_PGRS protein of Mycobacterium tuberculosis is surface exposed and influences bacterial cell structure.
Mol. Microbiol. 52:725–733.
19. Eda, S., et al. 2005. New method of serological testing for Mycobacterium
avium subsp. paratuberculosis (Johne’s disease) by flow cytometry. Foodborne Pathog. Dis. 2:250–262.
20. Emery, D. L., and R. J. Whittington. 2004. An evaluation of mycophage
therapy, chemotherapy and vaccination for control of Mycobacterium avium
subsp. paratuberculosis infection. Vet. Microbiol. 104:143–155.
21. Feller, M., et al. 2007. Mycobacterium avium subspecies paratuberculosis and
Crohn’s disease: a systematic review and meta-analysis. Lancet Infect. Dis.
7:607–613.

112

BANNANTINE ET AL.

22. Gey van Pittius, N. C., et al. 2006. Evolution and expansion of the Mycobacterium tuberculosis PE and PPE multigene families and their association with
the duplication of the ESAT-6 (esx) gene cluster regions. BMC Evol. Biol.
6:95.
23. Groenendaal, H., and D. T. Galligan. 2003. Economic consequences of
control programs for paratuberculosis in midsize dairy farms in the United
States. J. Am. Vet. Med. Assoc. 223:1757–1763.
24. Harris, N. B., and R. G. Barletta. 2001. Mycobacterium avium subsp. paratuberculosis in veterinary medicine. Clin. Microbiol. Rev. 14:489–512.
25. He, Z., and J. De Buck. 2010. Localization of proteins in the cell wall of
Mycobacterium avium subsp. paratuberculosis K10 by proteomic analysis.
Proteome Sci. 8:21.
26. Jha, S. S., et al. 2010. Virulence-related Mycobacterium avium subsp. hominissuis MAV_2928 gene is associated with vacuole remodeling in macrophages. BMC Microbiol. 10:100.
27. Kalis, C. H., M. T. Collins, J. W. Hesselink, and H. W. Barkema. 2003.
Specificity of two tests for the early diagnosis of bovine paratuberculosis
based on cell-mediated immunity: the Johnin skin test and the gamma
interferon assay. Vet. Microbiol. 97:73–86.
28. Lambrecht, R. S., J. F. Carriere, and M. T. Collins. 1988. A model for
analyzing growth kinetics of a slowly growing Mycobacterium sp. Appl. Environ. Microbiol. 54:910–916.
29. Li, L., et al. 2005. The complete genome sequence of Mycobacterium avium
subspecies paratuberculosis. Proc. Natl. Acad. Sci. U. S. A. 102:12344–12349.
30. Li, Y., E. Miltner, M. Wu, M. Petrofsky, and L. E. Bermudez. 2005. A
Mycobacterium avium PPE gene is associated with the ability of the bacterium to grow in macrophages and virulence in mice. Cell. Microbiol. 7:539–
548.
31. Livneh, A., et al. 2007. In vivo and in vitro characterization of Mycobacterium
avium subsp. paratuberculosis (MAP) mutants, p. 108–114. In E. J. B. Manning and S. S. Nielsen (ed.), Proceedings of the 8th International Colloquium
on Paratuberculosis. International Association of Paratuberculosis, Madison, WI.
32. McEvoy, C. R., P. D. van Helden, R. M. Warren, and N. C. Gey van Pittius.
2009. Evidence for a rapid rate of molecular evolution at the hypervariable
and immunogenic Mycobacterium tuberculosis PPE38 gene region. BMC
Evol. Biol. 9:237.
33. McKenna, S. L., et al. 2005. Comparison of two enzyme-linked immunosorbent assays for diagnosis of Mycobacterium avium subsp. paratuberculosis. J.
Vet. Diagn. Invest. 17:463–466.
34. McKenna, S. L. B., G. P. Keefe, H. W. Barkema, and D. C. Sockett. 2005.
Evaluation of three ELISAs for Mycobacterium avium subsp. paratuberculosis
using tissue and fecal culture as comparison standards. Vet. Microbiol.
110:105–111.
35. Nagata, R., Y. Muneta, K. Yoshihara, Y. Yokomizo, and Y. Mori. 2005.
Expression cloning of gamma interferon-inducing antigens of Mycobacterium
avium subsp. paratuberculosis. Infect. Immun. 73:3778–3782.
36. Newton, V., S. L. McKenna, and J. De Buck. 2009. Presence of PPE proteins
in Mycobacterium avium subsp. paratuberculosis isolates and their immunogenicity in cattle. Vet. Microbiol. 135:394–400.
37. Okkels, L. M., et al. 2003. PPE protein (Rv3873) from DNA segment RD1
of Mycobacterium tuberculosis: strong recognition of both specific T-cell
epitopes and epitopes conserved within the PPE family. Infect. Immun.
71:6116–6123.
38. Osterstock, J. B., G. T. Fosgate, N. D. Cohen, J. N. Derr, and A. J. Roussel.
2008. Familial and herd-level associations with paratuberculosis enzymelinked immunosorbent assay status in beef cattle. J. Anim. Sci. 86:1977–1983.
39. Osterstock, J. B., et al. 2007. Contribution of environmental mycobacteria to
false-positive serum ELISA results for paratuberculosis. J. Am. Vet. Med.
Assoc. 230:896–901.
40. Ott, S. L., S. J. Wells, and B. A. Wagner. 1999. Herd-level economic losses
associated with Johne’s disease on US dairy operations. Prev. Vet. Med.
40:179–192.
41. Parra, M., N. Cadieux, T. Pickett, V. Dheenadhayalan, and M. J. Brennan.

CLIN. VACCINE IMMUNOL.

42.

43.

44.

45.

46.

47.

48.
49.

50.
51.
52.

53.

54.

55.

56.
57.

58.

59.

60.

61.

62.

2006. A PE protein expressed by Mycobacterium avium is an effective T-cell
immunogen. Infect. Immun. 74:786–789.
Pearce, B. H., et al. 2008. Comparison of three methods of surveillance with
application to the detection of Johne’s disease seropositivity in Texas cattle.
Prev. Vet. Med. 86:1–7.
Plotkin, J. B., J. Dushoff, and H. B. Fraser. 2004. Detecting selection using
a single genome sequence of M. tuberculosis and P. falciparum. Nature
428:942–945.
Price, M. N., E. J. Alm, and A. P. Arkin. 2005. Interruptions in gene expression drive highly expressed operons to the leading strand of DNA replication. Nucleic Acids Res. 33:3224–3234.
Price, M. N., K. H. Huang, E. J. Alm, and A. P. Arkin. 2005. A novel method
for accurate operon predictions in all sequenced prokaryotes. Nucleic Acids
Res. 33:880–892.
Riley, R., M. Pellegrini, and D. Eisenberg. 2008. Identifying cognate binding
pairs among a large set of paralogs: the case of PE/PPE proteins of Mycobacterium tuberculosis. PLoS Comput. Biol. 4:e1000174.
Rockey, D. D., and J. L. Rosquist. 1994. Protein antigens of Chlamydia
psittaci present in infected cells but not detected in the infectious elementary
body. Infect. Immun. 62:106–112.
Rost, B., G. Yachdav, and J. Liu. 2004. The PredictProtein server. Nucleic
Acids Res. 32:W321–W326.
Sassetti, C. M., and E. J. Rubin. 2003. Genetic requirements for mycobacterial survival during infection. Proc. Natl. Acad. Sci. U. S. A. 100:12989–
12994.
Semret, M., C. Y. Turenne, and M. A. Behr. 2006. Insertion sequence IS900
revisited. J. Clin. Microbiol. 44:1081–1083.
Stabel, J. R. 1998. Johne’s disease: a hidden threat. J. Dairy Sci. 81:283–288.
Stinear, T. P., et al. 2008. Insights from the complete genome sequence of
Mycobacterium marinum on the evolution of Mycobacterium tuberculosis.
Genome Res. 18:729–741.
Stott, A. W., G. M. Jones, R. W. Humphry, and G. J. Gunn. 2005. Financial
incentive to control paratuberculosis (Johne’s disease) on dairy farms in the
United Kingdom. Vet. Rec. 156:825–831.
Strong, M., et al. 2006. Toward the structural genomics of complexes: crystal
structure of a PE/PPE protein complex from Mycobacterium tuberculosis.
Proc. Natl. Acad. Sci. U. S. A. 103:8060–8065.
Sweeney, R. W., et al. 2009. Effect of subcutaneous administration of a killed
Mycobacterium avium subsp. paratuberculosis vaccine on colonization of tissues following oral exposure to the organism in calves. Am. J. Vet. Res.
70:493–497.
Tekaia, F., et al. 1999. Analysis of the proteome of Mycobacterium tuberculosis in silico. Tuber. Lung Dis. 79:329–342.
Tiwari, A., et al. 2007. Production effects of pathogens causing bovine leukosis, bovine viral diarrhea, paratuberculosis, and neosporosis. J. Dairy Sci.
90:659–669.
Tundup, S., Y. Akhter, D. Thiagarajan, and S. E. Hasnain. 2006. Clusters of
PE and PPE genes of Mycobacterium tuberculosis are organized in operons:
evidence that PE Rv2431c is co-transcribed with PPE Rv2430c and their
gene products interact with each other. FEBS Lett. 580:1285–1293.
Vordermeier, M., S. V. Gordon, and A. R. Hewinson. 2009. Antigen mining
to define Mycobacterium bovis antigens for the differential diagnosis of vaccinated and infected animals: a VLA perspective. Transbound. Emerg. Dis.
56:240–247.
Wells, J. E., et al. 2009. Prevalence of Mycobacterium avium subsp. paratuberculosis in ileocecal lymph nodes and on hides and carcasses from cull cows
and fed cattle at commercial beef processing plants in the United States. J.
Food Prot. 72:1457–1462.
Whitlock, R. H., and C. Buergelt. 1996. Preclinical and clinical manifestations of paratuberculosis (including pathology). Vet. Clin. North Am. Food
Anim. Pract. 12:345–356.
Whitlock, R. H., S. J. Wells, R. W. Sweeney, and J. Van Tiem. 2000. ELISA
and fecal culture for paratuberculosis (Johne’s disease): sensitivity and specificity of each method. Vet. Microbiol. 77:387–398.

